JUN 06, 2018 5:54 AM PDT

Computer Simulations Offer Alternative Methods for Diabetic Drugs

WRITTEN BY: Nouran Amin

The Governor's Chair for Molecular Biophysics at the University of Tennessee (Knoxville), Jeremy Smith, and the director for the Center for Molecular Biophysics at Oak Ridge National Laboratory, has collaborated with a research team from UT Health Science Center to find a chemical substance that may lower glucose levels in the same efficacy as the common diabetic metformin but with the possibility of being administered in lower dose.

Smith, in collaboration with Jerome Baudry, of the University of Alabama (Huntsville) as well as graduate student Karan Kapoor, from the University of Illinois at Urbana-Champaign, studied high-performance computing to develop sophisticated simulations that suggest chemicals that could activate GPRC6A, which is protein that regulates sugar levels while at the same time corrects abnormalities in pancreatic insulin secretion, glucose uptake into skeletal muscle, and the regulation of glucose and fat metabolism in the liver.

"This chemical compound lowers sugar levels in mice as effectively as metformin, but with a 30-times lower dose," Smith said. "It therefore is a good starting point for the development of a new and effective drug to fight diabetes."

Wolrdwide, about 400 million people suffer from Type 2 diabetes. The global cost of treatment and management of this metabolic disorder is estimated to be a trillion dollars annually. Metformin, a common diabetic drug that works to reduce the liver's production of sugar and lessen the risk of mortality, is currently first-line medication treatment by physicians. However, there remains a dire need for an alternative treatment option for patients who do not respond to metformin as well as others.

 

The computations derived from the research study confirmed that multiple chemical compounds, tested each by the Quarles laboratory at UTHSC, may activate the GPRC6A protein. Furthermore, a team of UTHSC medicinal investigators utilized the results from the research study to synthesize related molecules for pre-clinical testing use. The chemical compound by the name of ‘DJ-V-159’ was identified and concluded to be highly potent in inducing insulin secretion and decreasing glucose levels in mouse models.

 

Source: University of Tennessee at Knoxville

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
MAY 06, 2021
Cannabis Sciences
New CBD Analog Outperforms Regular CBD for Pain Relief
MAY 06, 2021
New CBD Analog Outperforms Regular CBD for Pain Relief
Researchers from Temple University Health System have found that a novel cannabidiol (CBD) analog can reverse pain sensi ...
MAY 18, 2021
Immunology
A Silver Bullet Against COVID Variants?
MAY 18, 2021
A Silver Bullet Against COVID Variants?
Canadian researchers have discovered an antiviral drug that blocks the SARS-CoV-2 virus from infecting lung cells. Promi ...
MAY 22, 2021
Drug Discovery & Development
Drug Combo Treats 86% of Patients with Gout
MAY 22, 2021
Drug Combo Treats 86% of Patients with Gout
Researchers at the University of Michigan have found that a combination of two drugs is twice as effective as current tr ...
JUN 03, 2021
Drug Discovery & Development
Smartphone App More Effective than Traditional Treatment for Osteoarthritis
JUN 03, 2021
Smartphone App More Effective than Traditional Treatment for Osteoarthritis
  Researchers at the University of Nottingham in the UK and Joint Academy have found that a clinical evidence-based ...
JUL 12, 2021
Drug Discovery & Development
Testosterone Supplements Reduce Heart Attack and Stroke Risk
JUL 12, 2021
Testosterone Supplements Reduce Heart Attack and Stroke Risk
Taking testosterone supplements significantly reduces risk of heart attack and stroke among men with low levels of the h ...
JUL 29, 2021
Drug Discovery & Development
A low-cost drug for the treatment of hepatitis.
JUL 29, 2021
A low-cost drug for the treatment of hepatitis.
      The viral disease, Hepatitis C, is known as a silent killer. Hepatitis C is easily spread thro ...
Loading Comments...